‘Watching my six year old deadlift 35kg was pretty cool’: meet the children who work out

A growing number of parents are letting their young children train with weights. But is it a good – or safe – idea? We ask the experts to weigh in

Deafening, draining and potentially deadly: are we facing a snoring epidemic?

Experts say dangerous sleep apnoea affects an estimated 8 million in the UK alone, and everything from evolution to obesity or even the climate crisis could be to blame

‘No place in children’s hands’: under-16s in England to be banned from buying energy drinks

Government to ban sale of energy drinks with more than 150mg of caffeine, citing concerns over obesity and lack of concentration

‘I lost so much weight, my husband thought I was terminally ill’: why do people lie about taking Ozempic?

The dramatic results of weight-loss drugs often come with a side order of stigma, as though it’s ‘cheating’ not to stick to willpower, diet and exercise alone. Is that why so many are telling no one – not even their partners?

Health insurer Vitality is first to offer UK members weight-loss jabs

Company will give up to 20% off treatments such as Wegovy and Mounjaro through private cover

Soft spaces out, stick-fighting in: Dutch call for the return of risky play

Encouraging kids to play with fire? Hear us out, says party worried by the Netherlands’ increasingly sedentary ways

‘Wild west’: experts concerned by illegal promotion of weight-loss jabs in UK

Guardian review finds many online pharmacies flouting strict advertising rules that govern prescription-only drugs

Time for a noodle tax? Doctor who sounded alarm on ultra-processed food urges tougher action

Carlos Monteiro says the links between UPF and obesity, diabetes and even mental ill health are so strong that manufacturers should face taxes just like tobacco firms

Ozempic or Wegovy can be a godsend, but their non-medical use is alarming

Semaglutides are powerful drugs that carry risks, not tools for rapid weight loss, says professor of public health Devi Sridhar

Mounjaro is second obesity drug to be approved for use in England

Those with BMI of 35 and a comorbidity could be prescribed tirzepatide and Nice says it is more effective than Wegovy